This prospectus supplement corrects a typographical error in the amount being registered and increases the aggregate amount of common stock intended to be sold under the At-the-Market Issuance Sales Agreement. As of November 3, 2026, the company is offering up to an additional $5,228,226 of common stock for sale, bringing the total amount offered to approximately $6,528,226 (including previously sold shares). The company's outstanding common stock held by non-affiliates has an aggregate market value of approximately $27,684,678, based on 1,813,011 shares at $15.27 per share (closing price on September 4, 2026). The sale is subject to the restriction that no more than one-third of the aggregate market value of non-affiliated common stock may be sold in any 12-month period, provided the aggregate market value remains below $75,000,000. The last reported sale price of the common stock on the Nasdaq Capital Market was $2.91 per share on October 30, 2026. Investing in the common stock involves high risk, and investors are advised to review the "Risk Factors" section for detailed information. The Securities and Exchange Commission has not approved or disapproved the securities, and the prospectus supplement is qualified by reference to the Prior Prospectus.